Invention Grant
- Patent Title: Deuterated JAK inhibitor and uses thereof
-
Application No.: US17327044Application Date: 2021-05-21
-
Publication No.: US11919907B2Publication Date: 2024-03-05
- Inventor: I. Robert Silverman , Changhua Liu
- Applicant: Sun Pharmaceutical Industries, Inc.
- Applicant Address: US NJ Princeton
- Assignee: Sun Pharmaceutical Industries, Inc.
- Current Assignee: Sun Pharmaceutical Industries, Inc.
- Current Assignee Address: US NJ Princeton
- Agency: FOLEY HOAG LLP
- Main IPC: C07D487/04
- IPC: C07D487/04 ; A61K45/06
Abstract:
Disclosed is a JAK1 and/or JAK2 inhibitor of the following structural formula:
or a pharmaceutically acceptable salt thereof. This invention also provides pharmaceutical compositions comprising a compound of Formula (I), optionally including additional therapeutic agents, and use in methods of treatment for hair loss disorders.
or a pharmaceutically acceptable salt thereof. This invention also provides pharmaceutical compositions comprising a compound of Formula (I), optionally including additional therapeutic agents, and use in methods of treatment for hair loss disorders.
Public/Granted literature
- US20210387991A1 NOVEL DEUTERATED JAK INHIBITOR AND USES THEREOF Public/Granted day:2021-12-16
Information query
